A Double-Masked Placebo Controlled Clinical Trial of the Postoperative Opioid Sparing Effects of Intraoperative Dexmedetomidine Infusion for Thoracic Surgery
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 10 Feb 2017
At a glance
- Drugs Dexmedetomidine (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- 07 Feb 2017 Planned primary completion date changed from 1 Oct 2017 to 1 Oct 2018.
- 07 Feb 2017 Status changed from recruiting to active, no longer recruiting.
- 01 Nov 2016 Planned number of patients changed from 280 to 335.